According to PetIQ's latest financial reports the company has โน7.28 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โน9.68 B | 15.61% |
2022-12-31 | โน8.37 B | 41.78% |
2021-12-31 | โน5.91 B | 141.55% |
2020-12-31 | โน2.44 B | 25.81% |
2019-12-31 | โน1.94 B | -58.09% |
2018-12-31 | โน4.64 B | 91.76% |
2017-12-31 | โน2.41 B | 4542.42% |
2016-12-31 | โน52.12 M | -75.87% |
2015-12-31 | โน0.21 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | โน1.42 B | -80.52% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | โน37.77 B | 418.24% | ๐บ๐ธ USA |